Fredrik Kahn1, Fredrik Resman2, Sissela Bergmark3, Peter Filiptsev3, Bo Nilson4, Patrik Gilje5, Magnus Rasmussen6. 1. Skåne University Hospital, Sweden; Division of Infection Medicine, Department of Clinical Sciences Lund, Sweden. 2. Skåne University Hospital, Sweden; Division of Infectious Diseases, Department of Translational Medicine, Lund University, Malmö, Sweden. 3. Skåne University Hospital, Sweden. 4. Clinical Microbiology, Labmedicine, Region Skåne, Lund, Sweden; Division of Medical Microbiology, Department of Laboratory Medicine, Sweden. 5. Skåne University Hospital, Sweden; Division of Cardiology, Department of Clinical Sciences, Lund University, Sweden. 6. Skåne University Hospital, Sweden; Division of Infection Medicine, Department of Clinical Sciences Lund, Sweden. Electronic address: magnus.rasmussen@med.lu.se.
Abstract
OBJECTIVES: Patients with Staphylococcus aureus bacteraemia (SAB) at risk for infective endocarditis (IE) need to be identified because they should undergo echocardiography. We validated previous scoring systems for IE risk determination and evaluated whether time to blood culture positivity (TTP) could improve scoring systems. METHODS: This retrospective population-based study included adults with SAB in 2016 in a derivation cohort and those from 2017 in a validation cohort. TTP was compared between patients with and without IE. A new score including TTP was constructed using a least absolute shrinkage selection operator. The new POSITIVE score was compared to the previously described PREDICT and VIRSTA scores. RESULTS: A total of 465 episodes with SAB were included in the derivation cohort, of which 38 (8.2%) represented IE. Median (interquartile range) TTP was significantly shorter in episodes with IE, at 8.7 (7.7-10.6) hours compared to those without, at 13.3 (10.5-16.5) hours. When using a cutoff at 13 hours, TTP had a sensitivity of 100% (95% confidence interval (CI), 91-100) and specificity of 52% (95% CI, 47-57) for IE. The POSITIVE score included TTP, intravenous drug use, embolizations and presence of preexisting heart conditions. It had a sensitivity of 93% (95% CI, 76-99) and a specificity of 70% (95% CI, 66-74) in the validation cohort. The performance of POSITIVE was superior to PREDICT, and the specificity was higher than that of VIRSTA. CONCLUSIONS: TTP, either by itself or as part of the POSITIVE score, can be used to identify patients with SAB at low risk for IE. Further validation is needed because TTP is sensitive to several external factors.
OBJECTIVES: Patients with Staphylococcus aureus bacteraemia (SAB) at risk for infective endocarditis (IE) need to be identified because they should undergo echocardiography. We validated previous scoring systems for IE risk determination and evaluated whether time to blood culture positivity (TTP) could improve scoring systems. METHODS: This retrospective population-based study included adults with SAB in 2016 in a derivation cohort and those from 2017 in a validation cohort. TTP was compared between patients with and without IE. A new score including TTP was constructed using a least absolute shrinkage selection operator. The new POSITIVE score was compared to the previously described PREDICT and VIRSTA scores. RESULTS: A total of 465 episodes with SAB were included in the derivation cohort, of which 38 (8.2%) represented IE. Median (interquartile range) TTP was significantly shorter in episodes with IE, at 8.7 (7.7-10.6) hours compared to those without, at 13.3 (10.5-16.5) hours. When using a cutoff at 13 hours, TTP had a sensitivity of 100% (95% confidence interval (CI), 91-100) and specificity of 52% (95% CI, 47-57) for IE. The POSITIVE score included TTP, intravenous drug use, embolizations and presence of preexisting heart conditions. It had a sensitivity of 93% (95% CI, 76-99) and a specificity of 70% (95% CI, 66-74) in the validation cohort. The performance of POSITIVE was superior to PREDICT, and the specificity was higher than that of VIRSTA. CONCLUSIONS: TTP, either by itself or as part of the POSITIVE score, can be used to identify patients with SAB at low risk for IE. Further validation is needed because TTP is sensitive to several external factors.
Authors: Miguel A Chavez; Satish Munigala; Carey-Ann D Burnham; Melanie L Yarbrough; David K Warren Journal: J Clin Microbiol Date: 2022-03-16 Impact factor: 11.677
Authors: Anna Bläckberg; Stina Svedevall; Katrina Lundberg; Bo Nilson; Fredrik Kahn; Magnus Rasmussen Journal: Open Forum Infect Dis Date: 2022-04-03 Impact factor: 4.423
Authors: Thomas W van der Vaart; Jan M Prins; Robin Soetekouw; Gitte van Twillert; Jan Veenstra; Bjorn L Herpers; Wouter Rozemeijer; Rogier R Jansen; Marc J M Bonten; Jan T M van der Meer Journal: Clin Infect Dis Date: 2022-04-28 Impact factor: 20.999
Authors: Jorge Calderón-Parra; Itziar Diego-Yagüe; Beatriz Santamarina-Alcantud; Susana Mingo-Santos; Alberto Mora-Vargas; José Manuel Vázquez-Comendador; Ana Fernández-Cruz; Elena Muñez-Rubio; Andrea Gutiérrez-Villanueva; Isabel Sánchez-Romero; Antonio Ramos-Martínez Journal: J Clin Med Date: 2022-03-09 Impact factor: 4.241